Marie Jaspard

789 total citations
17 papers, 309 citations indexed

About

Marie Jaspard is a scholar working on Infectious Diseases, Epidemiology and Emergency Medical Services. According to data from OpenAlex, Marie Jaspard has authored 17 papers receiving a total of 309 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 4 papers in Epidemiology and 4 papers in Emergency Medical Services. Recurrent topics in Marie Jaspard's work include Viral Infections and Outbreaks Research (6 papers), Disaster Response and Management (4 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Marie Jaspard is often cited by papers focused on Viral Infections and Outbreaks Research (6 papers), Disaster Response and Management (4 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Marie Jaspard collaborates with scholars based in France, United States and Guinea. Marie Jaspard's co-authors include Éric Caumes, Nicolas Véziris, Dhiba Marigot-Outtandy, J. Robert, Damien Le Dû, Yazdan Yazdanpanah, M. Jachym, Lorenzo Guglielmetti, Marie Lachâtre and Christine Bernard and has published in prestigious journals such as PLoS ONE, European Respiratory Journal and Emerging infectious diseases.

In The Last Decade

Marie Jaspard

14 papers receiving 299 citations

Peers

Countries citing papers authored by Marie Jaspard

Since Specialization

Citations

This map shows the geographic impact of Marie Jaspard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marie Jaspard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marie Jaspard more than expected).

Fields of papers citing papers by Marie Jaspard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marie Jaspard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marie Jaspard. The network helps show where Marie Jaspard may publish in the future.

Co-authorship network of co-authors of Marie Jaspard

This figure shows the co-authorship network connecting the top 25 collaborators of Marie Jaspard. A scholar is included among the top collaborators of Marie Jaspard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marie Jaspard. Marie Jaspard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Improving Ebola virus disease outbreak control through targeted post-exposure prophylaxis 2024 ·The Lancet Global Health ·(unknown), Placide Mbala, (unknown), Abdoulaye Touré, (unknown), (unknown), Richard Kojan, Éric D’Ortenzio, Bjørn Blomberg, Marie Jaspard	0
2	Perceptions of COVID-19 among communities of Conakry (Guinea): a qualitative study exploring the context of the ANRS COV33 Coverage-Africa therapeutic trial 2022 ·BMJ Open ·(unknown), (unknown), Mélanie Plazy, Caroline Martin, Camille Fritzell, Mamadou Sow, Fodé Amara Traoré, Marie Jaspard, Armel Poda, Denis Malvy, Olivier Marcy, Alexandre Délamou, Joanna Orne‐Gliemann	0
3	Ribavirin for treating Lassa fever: A systematic review of pre-clinical studies and implications for human dosing 2022 ·PLoS neglected tropical diseases ·Alex P. Salam, Alexandre Duvignaud, Marie Jaspard, Denis Malvy, Miles W. Carroll, Joel Tärning, Piero Olliaro, Peter Horby	33
4	Post-exposure prophylaxis following high-risk contact with Ebola virus, using immunotherapies with monoclonal antibodies, in the eastern Democratic Republic of the Congo: an emergency use program 2021 ·International Journal of Infectious Diseases ·Marie Jaspard, (unknown), (unknown), (unknown), (unknown), (unknown), Placide Mbala, Richard Kojan, Denis Malvy	9
5	Présentation clinique, survie et facteurs associés à la mortalité: une étude prospective dans trois centres COVID-19 en Afrique de l’Ouest 2021 ·Infectious Diseases Now ·Marie Jaspard, Mamadou Saliou Sow, (unknown), (unknown), (unknown), Richard Kojan, Armel Poda, Alpha Kabinet Kéita, Xavier Anglaret, Denis Malvy	2
6	Linezolid-Associated Neurologic Adverse Events in Patients with Multidrug-Resistant Tuberculosis, France 2020 ·Emerging infectious diseases ·Marie Jaspard, (unknown), Najoua El Helali, Dhiba Marigot-Outtandy, Hélène Guillot, Gilles Peytavin, Nicolas Véziris, Bahram Bodaghi, Philippe Flandre, (unknown), Éric Caumes, Valérie Pourcher	38
7	Rasmussen aneurysm in a patient from the Ukraine: A diagnostic challenge 2020 ·Travel Medicine and Infectious Disease ·Marie Jaspard, Françoise Le Pimpec‐Barthes, Éric Caumes	2
8	Delayed-onset paraparesis in Lassa fever: A case report 2019 ·International Journal of Infectious Diseases ·Alexandre Duvignaud, (unknown), Chukwuyem Abejegah, (unknown), Marie Jaspard, (unknown), (unknown), Claire Lévy‐Marchal, Xavier Anglaret, (unknown), (unknown), Denis Malvy, (unknown)	6
9	Clinical management of respiratory syndrome in patients hospitalized for suspected Middle East respiratory syndrome coronavirus infection in the Paris area from 2013 to 2016 2018 ·BMC Infectious Diseases ·Alexandre Bleibtreu, Stéphane Jauréguiberry, Nadira Houhou, David Boutolleau, Hélène Guillot, D. Vallois, Jean Christophe Lucet, J. Robert, Bruno Mourvillier, Julie Delemazure, Marie Jaspard, (unknown), C. Rioux, Éric Caumes, (unknown)	29
10	Tuberculose MDR/XDR : tolérance d’un traitement prolongé par linézolide 2018 ·Médecine et Maladies Infectieuses ·Marie Jaspard, (unknown), Hélène Guillot, Gilles Peytavin, Nicolas Véziris, Éric Caumes, (unknown), (unknown), Najoua El Helali, Valérie Pourcher	1
11	Chronic hepatitis E in HIV/HBV coinfected patient 2017 ·AIDS ·Ève Todesco, Sophie Demeret, Ruxandra Câlin, Anne‐Marie Roque‐Afonso, Vincent Thibault, Vincent Mallet, Sepideh Akhavan, Marie Jaspard, Gilles Peytavin, Thierry Poynard, Christine Katlama, (unknown)	19
12	Bedaquiline and Linezolid for Extensively Drug-Resistant Tuberculosis in Pregnant Woman 2017 ·Emerging infectious diseases ·Marie Jaspard, (unknown), (unknown), (unknown), Nicolas Véziris, Éric Caumes	20
13	Rickettsia sibirica mongolitimonae infection in a woman travelling from Cameroon: a case report and review of the literature 2017 ·Journal of Travel Medicine ·(unknown), Gentiane Monsel, Marie Jaspard, (unknown), Emmanouil Angelakis, Éric Caumes	10
14	Bilan d’activité du centre de traitement Ebola de Forécariah (Guinée) du 23 avril au 5 juin 2015 : analyse et réflexions 2016 ·Bulletin de la Société de pathologie exotique ·Bernard-Alex Gaüzère, (unknown), (unknown), (unknown), (unknown), Alimou Camara, D. Camara, (unknown), (unknown), (unknown), (unknown), Vanessa Monteil, (unknown), (unknown), (unknown), Daouda Sissoko, (unknown), Marie Jaspard, Tuan Tran-Minh, F. L’Hériteau	0
15	Long-term outcome and safety of prolonged bedaquiline treatment for multidrug-resistant tuberculosis 2016 ·European Respiratory Journal ·Lorenzo Guglielmetti, Marie Jaspard, Damien Le Dû, Marie Lachâtre, Dhiba Marigot-Outtandy, Christine Bernard, Nicolas Véziris, J. Robert, Yazdan Yazdanpanah, Éric Caumes, M. Jachym	103
16	Finger-Stick Whole Blood HIV-1/-2 Home-Use Tests Are More Sensitive than Oral Fluid-Based In-Home HIV Tests 2014 ·PLoS ONE ·Marie Jaspard, G. Le Moal, (unknown), (unknown), (unknown), (unknown), Aurélie Guigon, Laurent Hocqueloux, Thiérry Prazuck	34
17	Quand un des petits-enfants présente un handicap 2002 ·Dialogue ·Marie Jaspard	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact